Jessica L. Restivo

ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Donald A. Wilson, D. Wesson, G. Landreth, 2012, Science.

Opposing Synaptic Regulation of Amyloid-β Metabolism by NMDA Receptors In Vivo

D. Holtzman, J. Cirrito, Jessica L. Restivo, 2011, The Journal of Neuroscience.

A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's disease

D. Holtzman, J. Cirrito, B. Timson, 2016, Neurobiology of Disease.

Immune function in Trachemys scripta following exposure to a predominant brevetoxin congener, PbTx-3, as a model for potential health impacts for sea turtles naturally exposed to brevetoxins

S. Milton, Jessica L. Restivo, L. Flewelling, 2019, Ecotoxicology.

Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice

Andrew W. Kraft, D. Holtzman, Qingli Xiao, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans

M. Mintun, J. Morris, Y. Sheline, 2011, Proceedings of the National Academy of Sciences.

In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis

D. Holtzman, G. Landreth, J. Ulrich, 2013, Molecular Neurodegeneration.

microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain

D. Holtzman, C. Ramírez, C. Fernández-Hernando, 2015, The Journal of Neuroscience.

Rapid in vivo measurement of β-amyloid reveals biphasic clearance kinetics in an Alzheimer’s mouse model

G. Bu, Katherine L. Young, J. Cirrito, 2016, The Journal of experimental medicine.

Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice

D. Holtzman, S. Paul, J. Cirrito, 2012, Brain Research.

Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo

D. Holtzman, M. Sano, D. Westaway, 2009, Molecular Neurodegeneration.